Evidence in Obese Children: Contribution of Hyperlipidemia, Obesity-Inflammation, and Insulin Sensitivity

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Chang, Chi Jen ^a,b   Jian, Deng Yuan ^c,d   Lin, Ming Wei ^c,e   Zhao, Jun Zhi ^a   Ho, Low Tone ^c,e   Juan, Chi Chang ^c,e,f  

^a Shin Kong Wu Ho Su Hospital   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d Division of Nephrology   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

ADOLESCENT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ELISA KIT; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; MALE; OBESITY; PREDICTION; PROTEIN DETERMINATION; BLOOD; COMPLICATION; PRINCIPAL COMPONENT ANALYSIS; TAIWAN;

ADOLESCENT; BIOMARKERS; CHILD; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN; MALE; OBESITY; PRINCIPAL COMPONENT ANALYSIS; TAIWAN;

EID: 84953404147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125935     Document Type: Article

References (60)

1. Nasreddine L, Naja F, Chamieh MC, Adra N, Sibai AM, Hwalla N. Trends in overweight/obesity in Lebanon: evidence from two national cross-sectional surveys (1997 and 2009). BMC Public Health. 2012; 12:798. doi: 10.1186/1471-2458-12-798 PMID: 22984791
2. Lopez KN, Knudson JD. Obesity: from the agricultural revolution to the contemporary pediatric epidemic. Congenit Heart Dis. 2012; 7:189-199. doi: 10.1111/j.1747-0803.2011.00618.x PMID: 22304860
3. Orsi CM, Hale DE, Lynch JL. Pediatric obesity epidemiology. Curr Opin Endocrinol Diabetes Obes. 2011; 18:14-22. doi: 10.1097/MED.0b013e3283423de1 PMID: 21157323
4. Saffari F, Jalilolghadr S, Esmailzadehha N, Azinfar P. Metabolic syndrome in a sample of the 6-to 16-year-old overweight or obese pediatric population: a comparison of two definitions. Ther Clin Risk Manag. 2012; 8:55-63. doi: 10.2147/TCRM.S26673 PMID: 22346358
5. Deboer MD. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition. 2013; 29:379-386. doi: 10.1016/j.nut.2012.07.003 PMID: 23022122
6. Vykoukal D, Davies MG. Biology of metabolic syndrome in a vascular patient. Vascular. 2012; 20:156-165. doi: 10.1258/vasc.2011.201201 PMID: 22700582
7. Da Costa LA, Arora P, García-Bailo B, Karmali M, El-Sohemy A, Badawi A. The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults. Diabetes Metab Syndr Obes. 2012; 5:347-355. doi: 10.2147/DMSO.S35115 PMID: 23055759
8. Cohen JI, Maayan L, Convit A. Preliminary evidence for obesity-Associated insulin resistance in adolescents without elevations of inflammatory cytokines. Diabetol Metab Syndr. 2012; 4:26. doi: 10.1186/1758-5996-4-26 PMID: 22682228
9. Wasilewska A, Tenderenda E, Taranta-Janusz K, Tobolczyk J, Stypukowska J. Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr. 2012; 101:497-500. doi: 10.1111/j.1651-2227.2011.02582.x PMID: 22211844
10. Breslin WL, Johnston CA, Strohacker K, Carpenter KC, Davidson TR, Moreno JP, et al. Obese Mexican American children have elevated MCP-1, TNF-?, monocyte concentration, and dyslipidemia. Pediatrics. 2012; 129:e1180-e1186. doi: 10.1542/peds.2011-2477 PMID: 22473371
11. Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragón-Alonso A, Pascual-Díaz M, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-Alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012; 22:950-955. doi: 10.1007/s11695-012-0643-y PMID: 22527592
12. Utsal L, Tillmann V, Zilmer M, Mäestu J, Purge P, Jürimäe J, et al. Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-? levels in 10-to 11-year-old boys with increased BMI. Horm Res Paediatr. 2012; 78:31-39. doi: 10.1159/000339831 PMID: 22832157
13. Finucane OM, Reynolds CM, McGillicuddy FC, Roche HM. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance. Proc Nutr Soc. 2012; 22:1-12.
14. Lutgens E, Binder CJ. Immunology of atherosclerosis. Thromb Haemost. 2011; 106: 755-756. doi: 10. 1160/TH11-10-0683 PMID: 22011700
15. Taube A, Schlich R, Sell H, Eckardt K, Eckel J. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012; 302:H2148-H2165. doi: 10.1152/ajpheart. 00907.2011 PMID: 22447947
16. Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Cardiovascular metabolic syndrome-An interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab. 2007; 9:218-232. PMID: 17391148
17. Aycan Z, Berberolu M, Ocal G, Evliyaoglu O, Adiyaman P, Deda G, et al. Relationship between plasma leptin, insulin and tumor necrosis factor alpha in obese children. J Pediatr Endocrinol Metab. 2005; 18:275-284. PMID: 15813606
18. Brito N, Fonseca M, Dinis I, Mirante A. Metabolic factors in obesity. J Pediatr Endocrinol Metab. 2010; 23:97-100. PMID: 20432812
19. Pyrzak B, Ruminska M, Popko K, Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur J Med Res. 2010; 15:147-151. PMID: 21147643
20. Panagopoulou P, Galli-Tsinopoulou A, Fleva A, Pavlitou-Tsiontsi E, Vavatsi-Christaki N, Nousia-Arvanitakis S. Adiponectin and insulin resistance in childhood obesity. J Pediatr Gastroenterol Nutr. 2008; 47:356-362. doi: 10.1097/MPG.0b013e31817fcb67 PMID: 18728534
21. Rubin DA, Hackney AC. Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity. Med Sport Sci. 2010; 55:43-55. doi: 10.1159/000321971 PMID: 20956859
22. Garanty-Bogacka B, Syrenicz M, Goral J, Krupa B, Syrenicz J, Walczak M, et al. Changes in inflammatory biomarkers after successful lifestyle intervention in obese children. Endokrynol Pol. 2011; 62:499-505. PMID: 22144215
23. Hobkirk JP, King RF, Gately P, Pemberton P, Smith A, Barth JH, et al. Longitudinal factor analysis reveals a distinct clustering of cardiometabolic improvements during intensive, short-term dietary and exercise intervention in obese children and adolescents. Metab Syndr Relat Disord. 2012; 10:20-25. doi: 10.1089/met.2011.0050 PMID: 21936669
24. Montero D, Walther G, Perez-Martin A, Roche E, Vinet A. Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle intervention. Obes Rev. 2012; 13:441-455. doi: 10.1111/j.1467-789X.2011.00956.x PMID: 22133012
25. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. Am Heart J. 2005; 149:33-45. PMID: 15660032
26. Lin MW, Hwu CM, Huang YH, Sheu WH, Shih KC, Chiang FT, et al. Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension. Am J Hypertens. 2006; 19:1118-1124. PMID: 17070421
27. Stelzer I, Zelzer S, Raggam RB, Prüller F, Truschnig-Wilders M, Meinitzer A, et al. Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation. Transl Res. 2012; 159:118-124. doi: 10.1016/j.trsl.2011.10.001 PMID: 22243796
28. Valle M, Martos R, Gascón F, Cañete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes Metab. 2005; 31:55-62. PMID: 15803114
29. Abdullah AR, Hasan HA, Raigangar VL. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females. Metab Syndr Relat Disord. 2009; 7:17-22. doi: 10.1089/met.2008.0045 PMID: 19025443
30. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000; 320:1240-1243. PMID: 10797032
31. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502. PMID: 4337382
32. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015; 402C:113-119.
33. Becton LJ, Shatat IF, Flynn JT. Hypertension and obesity: epidemiology, mechanisms and clinical approach. Indian J Pediatr. 2012; 79:1056-1061. doi: 10.1007/s12098-012-0777-x PMID: 22664863
34. Flynn JT, Falkner BE. Obesity hypertension in adolescents: epidemiology, evaluation, and management. J Clin Hypertens (Greenwich). 2011; 13:323-331. doi: 10.1111/j.1751-7176.2011.00452.x PMID: 21545393
35. Nafiu OO, Zepeda A, Curcio C, Prasad Y. Association of neck circumference and obesity status with elevated blood pressure in children. J Hum Hypertens. 2014; 28:263-268. doi: 10.1038/jhh.2013.93 PMID: 24088717
36. Guo X, Li Y, Sun G, Yang Y, Zheng L, Zhang X, et al. Prehypertension in children and adolescents: association with body weight and neck circumference. Intern Med. 2012; 51:23-27. PMID: 22214619
37. Raj M. Obesity and cardiovascular risk in children and adolescents. Indian J Endocrinol Metab. 2012; 16:13-19. doi: 10.4103/2230-8210.91176 PMID: 22276248
38. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev. 2010; 6:58-67. PMID: 20034369
39. l'Allemand-Jander D. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child. Int J Obes (Lond). 2010; 34:S32-S36. doi: 10.1038/ijo.2010.237 PMID: 21151144
40. Arrigo T, Chirico V, Salpietro V, Munafó C, Ferraú V, Gitto E, et al. High-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol. 2013; 168:631-638. doi: 10. 1530/EJE-13-0037 PMID: 23384711
41. Mäestu J, Jürimäe J, Jürimäe T. Visfatin and adiponectin levels in children: relationships with physical activity and metabolic parameters. Med Sport Sci. 2010; 55:56-68. doi: 10.1159/000321972 PMID: 20956860
42. Jürimäe J, Gruodyte R, Saar M, Cicchella A, Stefanelli C, Passariello C, et al. Plasma visfatin and adiponectin concentrations in physically active adolescent girls: relationships with insulin sensitivity and body composition variables. J Pediatr Endocrinol Metab. 2011; 24:419-425. PMID: 21932575
43. Agueda M, Lasa A, Simon E, Ares R, Larrarte E, Labayen I. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes. Nutr Metab Cardiovasc Dis. 2012; 22:208-214. doi: 10.1016/j.numecd.2010.06.010 PMID: 20951014
44. Angn Y, Arslan N, Kuralay F. Leptin-to-Adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. Turk J Pediatr. 2014; 56:259-266. PMID: 25341597
45. Gong CD, Wu QL, Chen Z, Zhang D, Zhao ZY, Peng YM. Glycolipid metabolic status of overweight/obese adolescents aged 9-to 15-year-old and the BMI-SDS/BMI cut-off value of predicting dyslipidemiain boys, Shanghai, China: a cross-sectional study. Lipids Health Dis. 2013; 12:129. doi: 10.1186/1476-511X-12-129 PMID: 23984682
46. Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, Fraser A, et al. Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ. 2010; 341:c6224. doi: 10.1136/bmj.c6224 PMID: 21109577
47. Mokha JS, Srinivasan SR, Dasmahapatra P, Fernandez C, Chen W, Xu J, et al. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr. 2010; 10:73. doi: 10. 1186/1471-2431-10-73 PMID: 20937123
48. van Vliet M, Gazendam RP, von Rosenstiel IA, van Zanten AP, Brandjes DP, Beijnen JH, et al. Differential impact of impaired fasting glucose versus impaired glucose tolerance on cardiometabolic risk factors in multi-ethnic overweight/obese children. Eur J Pediatr. 2011; 170:589-597. doi: 10.1007/s00431-010-1323-3 PMID: 20960007
49. Friedemann C, Heneghan C, Mahtani K, Thompson M, Perera R, Ward AM. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-Analysis. BMJ. 2012; 345:e4759. doi: 10.1136/bmj.e4759 PMID: 23015032
50. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000; 152:908-911. PMID: 11092432
51. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int J Obes Relat Metab Disord. 2001; 25:1782-1788. PMID: 11781758
52. Hanley AJ, Festa A, D'Agostino RB Jr., Wagenknecht LE, Savage PJ, Tracy RP, et al. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes. 2004; 53:1773-1781. PMID: 15220201
53. Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Fujimoto WY, et al. Factors of the insulin resistance syndrome in nondiabetic and diabetic elderly Japanese-American men. Am J Epidemiol. 1998; 147:441-447. PMID: 9525530
54. Charlton R, Gravenor MB, Rees A, Knox G, Hill R, Rahman MA, et al. Factors associated with low fitness in adolescents-A mixed methods study. BMC Public Health. 2014; 14:764. doi: 10.1186/1471-2458-14-764 PMID: 25074589
55. LaBresh KA, Ariza AJ, Lazorick S, Furberg RD, Whetstone L, Hobbs C, et al. Adoption of cardiovascular risk reduction guidelines: a cluster-randomized trial. Pediatrics. 2014; 134:e732-e738. doi: 10.1542/peds.2014-0876 PMID: 25157013
56. Garanty-Bogacka B, Syrenicz M, Syrenicz A, Gebala A, Lulka D, Walczak M. Serum markers of inflammation and endothelial activation in children with obesity-related hypertension. Neuro Endocrinol Lett. 2005; 26:242-246. PMID: 15990729
57. Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP Jr., Isaacsohn JL, et al. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation. 1996; 94:2381-2388. PMID: 8921777
58. Ding D, Li X, Qiu J, Li R, Zhang Y, Su D, et al. Serum lipids, apolipoproteins, and mortality among coronary artery disease patients. Biomed Res Int. 2014; 2014:709756. doi: 10.1155/2014/709756 PMID: 24982904
59. Mertens I, Van Gaal LF. Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med. 2005; 5:48-55. PMID: 15968580
60. Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-Analysis. Diabetes Care. 2013; 36:166-175. doi: 10.2337/dc12-0702 PMID: 23264288